The global secretariat of the Global Validation Advisory Committee (GVAC) on the validation of elimination of mother-to-child transmission and elimination of viral hepatitis B and C as a public health problem has considered the appointment of four new members to the Committee. The new members bring expertise crucial to viral hepatitis C elimination to the GVAC. With these appointments, the Global Validation Secretariat bolsters the capacity of the GVAC to conduct its mission for assessing whether countries have met the criteria for validation of hepatitis elimination as a public health problem.
The new members are:
- Dr Kimberly Green , Global Director for Primary Health Care (PHC), PATH, United States of America. Dr Green will bring expertise in prevention and service delivery of viral hepatitis.
- Ms Rachel Halford , Chief Executive Officer, The Hepatitis C Trust, United Kingdom of Great Britain and Northern Ireland. Ms Halford will bring expertise in civil society, human rights, community engagement and lived experience of hepatitis C.
- Dr Ajeet Singh Bhadoria , Additional Professor, Department of Community and Family Medicine, All India Institute of Medical Sciences, India. Dr Singh Bhadoria will bring expertise in epidemiology of liver diseases, patient care and services for viral hepatitis.
- Dr Ibou Thior , Senior Technical Adviser, PATH, United States of America. Dr Thior will bring expertise in viral hepatitis research, blood safety and injection safety for prevention of hepatitis C.
To enhance WHO's management of conflicts of interes t, as well as strengthen public trust and transparency in connection with WHO advisory groups involving the provision of technical advice, the names and brief biographies of individuals being considered for assignment to WHO advisory groups are disclosed for public notice and comment.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the attention of WHO through this process are an integral component of WHO's conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publicly in accordance with WHO practice.
